Angela Douglas, a Consultant Clinical Scientist, is the Deputy Chief Scientific officer for NHS England. Angela has worked in the NHS in Genetics for over 38 years, is a Fellow of the Royal College of Pathologists, and an Honorary Fellow of the Academy for Healthcare Science. Angela previously worked as the Scientific Director of the Cheshire and Merseyside Genetics Service, at Liverpool Women’s Hospital, for 22 years, where she was the Organisational Lead Healthcare Scientist, and more recently led the NW Coast GMC delivering the 100,000 Genome Project as the Clinical Programme Director. In 2012, Angela was nominated as President of the British Society for Genetic Medicine, having previously been the Chairman of the ACC and the ACGS.
Angela was a member of the working groups (Service Delivery, Innovation and Bioinformatics) of the Human Genomics Strategy Group (HGSG) that provided the evidence and recommendations for the Department of Health’s Genomics Review in 2012, and continues to work with the group to ensure their recommendations are delivered. Angela is a member of the Genomics England Rare Diseases Working Group and advises on the development of Protocols for the GMC Projects.
Angela is a member of the Department of Health’s UK Rare Disease Advisory Group, and has just completed a term of office as Chair of the RCPath Genetics and Reproductive Medicine Scientific Advisory Committee and was the RCPath Scientific Workforce Lead. After having chaired the Cheshire and Merseyside HCS Network for 10 years, Angela was appointed as the NW Lead Scientist and worked with NHS E, HEE, the AHSNs and the AHCS, supporting Healthcare Science disciplines, including Genetics and Bioinformatics across the NW.
Angela was previously seconded to a National role to ensure safe and sustainable Healthcare Science Diagnostic Services across England as a Specialist Advisor to the office of the CSO at NHS E. In 2014, Angela was named in the HSJ as one of UKs top 50 Inspirational Women Leaders, in 2015 was awarded Healthcare Scientist of the Year by NHS E, and in 2016 was honored in the Queens 90th Birthday Honors list as a Member of the Order of the British Empire for Research and Mentoring Students.
Sarah is the Associate Director of the NICE Diagnostics Assessment programme and has a keen interest in the value of diagnostics to patients and the healthcare system. She is leading on work in genomics, precision medicine and AMR diagnostic technologies at NICE, and is also Chair of the Equality Group for the NICE Centre of Health Technology Evaluation. Prior to joining NICE, Sarah completed a PhD in Biochemistry with the University of Manchester and GlaxoSmithKline, and then spent time working in research and development at AstraZeneca.
Doris-Ann Williams has been Chief Executive of BIVDA since October 2001. She has more than 35 years’ experience in the IVD sector. She has held a variety of roles, initially in R&D at Amersham International/Amerlite Diagnostics Ltd and subsequently in commercial roles internationally for Becton Dickinson, ICN and Hitachi Chemical Diagnostics.
Doris-Ann also works closely with other global IVD industry associations and in the UK as part of Life Sciences UK. She was awarded an MBE in January 2011 and was recognised as a Friend of the Royal College of Pathologists in November 2012 and also as Friend of the Association for Clinical Biochemistry in July 2015.
My research interests lie in diagnosis and management of common infections in primary care and in the generation of evidence for new diagnostic technologies in primary care settings. I am also interested in characterising the work of the primary care Out-of-Hours services and exploring the ways this service could be improved by use of new technologies or different models of care.
I am the Deputy Director of the NIHR Community Healthcare MedTech and IVD Cooperative. I am PI of CONDUCT, a large RCT evaluating methods for reducing urine sample contamination rates, and PROBE, a mixed methods study exploring the clinical impact of point of care blood testing in the out of hours service. I was joint PI of the TOAST trial, a large RCT comparing oral dexamethasone to placebo for symptom relief of acute sore throat. Other current projects include qualitative interviews to explore the GPs use of the diagnostic markers of infection in the elderly and a methods comparison study of thermometers for children aged 5 and under. I sit on the NHS England AMR Diagnostic Collaborative.
Clare joined NIBSC in 1998 as a scientist responsible for screening plasma pools for the presence of HIV, following a 2-year graduate post at Hammersmith Hospital working on an HIV drug response clinical trial.
She now has over 16 years of experience in the field of development of international standards and working reagents.
Her main interests are the development of international standards for use in clinical diagnosis and the improvement of current standards to adapt to new technologies.
With over 30 years’ experience in high volume manufacturing automation, Timo has spent most of his career to date in various manufacturing automation sales and management roles within the Life Science and Electronics sectors. As European Sales Director of Ginolis, Timo works with Ginolis distributors and medical device customers to deliver the best technical solutions for their production automation when it comes to dispensing and manufacturing automation solutions, inspection equipment and micro automation.
Cheryl graduated from Cardiff University with an honours degree in pharmacy.
She completed pre-registration training in the pharmaceutical industry and hospitals in Surrey. She joined the NHS as a medicines information pharmacist in the Welsh Medicines Information Centre, then worked as a hospital pharmacist at Cardiff Royal Infirmary before becoming Pharmacy Manager for Cardiff Royal Group of Hospitals.
She obtained a Master’s degree in Healthcare Management from the University of Glamorgan in 1996. She worked at the University Hospital of Wales before becoming Pharmacy Manager at University Hospital Llandough in 2001. She joined Informing Healthcare, now NHS Wales Informatics Service, as National Pharmacy and Medicines Management Lead in 2006.
She completed the Leaders for Change Programme with The Health Foundation in 2009 and received the Leaders for Collaboration certificate from Cardiff Metropolitan University in 2014. She was elected to the Welsh Board of the Royal Pharmaceutical Society in 2015, and awarded fellowship of the Society in 2017.
Business Manager, Academic Health Science Network for the North East and North Cumbria (AHSN NENC)
Stephen is a Business Manager at the Academic Health Science Network for the North East and North Cumbria (AHSN NENC) and is responsible for supporting companies wanting to access the NHS.
Stephen has a PhD in molecular biology and physiology from Newcastle University and went on to be a Post-Doctoral Fellow at Stanford University where he studied the link between oxidative stress and neurodegeneration.
Stephen then moved to the UK Foreign and Commonwealth Office at the British Consulate in San Francisco as the Vice-Consul for Science and Innovation where he was involved in policy development as well as trade and investment between the UK and the USA, and was the North America lead for the stem cells and regenerative medicine agenda.
After returning to the UK in 2007, Stephen was the project manager of a €10 million network of excellence, funded through FP6, to address the fragmentation in translational research for the assessment and treatment of rare neuromuscular diseases coordinated by Newcastle University. This network also allowed Newcastle University to lead on other major awards to develop new tools, resources and take a leading role on the issues affecting patients with rare diseases across Europe, in partnership with clinicians, academics, patients, industry and policy makers.
Before joining the AHSN, Stephen worked in the NHS as a Commercial Manager for Newcastle Hospitals NHS Foundation Trust with responsibility for business development activities involving medical technologies and diagnostics. There he helped to establish and launch Diagnostics North East, a partnership between the Newcastle Hospitals NHS Foundation Trust, Newcastle University and the AHSN for the North East and North Cumbria to deliver the various resources that map to the development, research and innovation of diagnostic technologies and available to both academic and commercial partners.